UNSPSC 51282321: Erythromycin glucoheptonate

This classification denotes a macrolide antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2AY21R0U64. European Medicines Agency schedules Erythromycin gluceptate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01943MIG. Erythromycin glucoheptonate generally arises in the molecular formula C37H67NO13.C7H14O8. The term 'erythromycin glucoheptonate' is a U.S. Pharmacopeial Convention designation.

Most nations, for tariff and trade purposes, schedule erythromycin glucoheptonate under HS 29415000 and SITC 54139. SMILES: CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O.C([C@H]([C@H]([C@@H]([C@H]([C@H](C(=O)O)O)O)O)O)O)O.

UNSPSC 51282321 Erythromycin glucoheptonate is a Commodity code for a specific injectable antibiotic pharmaceutical, yet the recent state and local opportunities tagged under it do not reflect purchases of erythromycin glucoheptonate itself. Instead, the code has been applied to pharmaceutical warehouse piggyback contracts and emergency-response medical supply procurements that span a broader range of drugs and medical devices, including antibiotics (Doxycycline Hyclate, Ciprofloxacin Hydrochloride), opioid antagonists (Naloxone), and drug deactivation systems. State and local buyers using this code are primarily county health departments and state public health agencies sourcing pharmaceutical inventory through cooperative purchasing vehicles such as MMCAP Infuse consortiums and direct IFB processes.

Recent activity centers in Florida and Illinois. The Illinois Department of Public Health awarded a $2,999,999.11 three-year piggyback contract to Chartwell Rx LLC through the MMCAP Infuse consortium in August 2026 for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets under IFB 26482DPHPREPDB53392, with a 12-month initial term and renewal options. Seminole County, Florida released IFB 60459723LAS on June 30, 2026, seeking annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries to the Seminole County Community Health Building in Sanford, response deadline July 26, 2023. The mismatch between the code's nominal scope (erythromycin glucoheptonate) and the actual pharmaceutical and medical device work being solicited suggests either miscoding in the state and local system or a broader application of the code to general pharmaceutical warehouse and emergency-response medical supply categories.